101
Participants
Start Date
March 19, 2018
Primary Completion Date
December 6, 2019
Study Completion Date
March 5, 2020
Pegilodecakin
Pegilodecakin plus Pembrolizumab
Pembrolizumab
Pembrolizumab Alone
Clinical Research Alliance, Inc., Lake Success
Winthrop University Hospital, Mineola
Stony Brook University Medical Center, Stony Brook
Medical Oncology Hematolgy Consultants, PA, Newark
Maryland Oncology Hematology, P.A., Columbia
MedStar Research Institute, Baltimore
Frederick Memorial Hospital, Frederick
Fairfax Northern Virginia Hematology Oncology, PC, Fairfax
Shenandoah Oncology, P.C., Winchester
Oncology and Hematology Associates of Southwest Virginia Inc, Roanoke
DJL Clinical Research, PLLC, Charlotte
Southeastern Medical Oncology Center, Jacksonville
Charleston Hematology Oncology Associates, Charleston
Northeast Georgia Cancer Care, LLC, Athens
SCRI- Florida Cancer Specialists, Tallahassee
Tallahassee Memorial Cancer Center, Tallahassee
Memorial Cancer Institute, Pembroke Pines
Florida Cancer Specialists East, West Palm Beach
Lynn Cancer Institute Ctr for Hem-Onc, Boca Raton
CCI - Clearview Cancer Institute, Huntsville
Sarah Cannon Research Institute SCRI, Nashville
Chattanooga Oncology Hematology Associates, Chattanooga
Thompson Cancer Survival Center, Knoxville
Hattiesburg Clinic, Hattiesburg
Norton Cancer Institute, Louisville
Baptist Health Medical Group, Lexington
The Toledo Clinic, Toledo
Gabrail Cancer Center, Canton
Christ Hospital, Cincinnati
Goshen Health System, Goshen
St. Joseph Mercy Hospital, Ann Arbor
Henry Ford Hospital Detroit, Detroit
Sparrow Health System, Lansing
Covenant Clinic, Waterloo
The Richland Hospital, Waukesha
Minnesota Oncology/Hematology PA, Minneapolis
University of Minnesota Hospital, Minneapolis
Avera Cancer Institute, Sioux Falls
Orchard Healthcare Research Inc, Skokie
AMITA Health Cancer Institute & Outpatient Center, Hinsdale
St John's Mercy Medical Center, St Louis
Menorah Medical Center, Overland Park
Nebraska Hematology-Oncology, Lincoln
Texas Oncology - Dallas Presbyterian Hospital, Dallas
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology - Tyler, Tyler
Texas Oncology-Wichital Falls Texoma Cancer Center, Wichita Falls
Texas Oncology-Memorial City, Houston
Millennium Oncology, Houston
US Oncology, The Woodlands
Mamie McFaddin Ward Cancer Center, Beaumont
Joe Arrington Cancer Center, Lubbock
Texas Cancer Center (Abilene), Abilene
Texas Oncology - Midland Allison Cancer Center, Midland
Rocky Mountain Cancer Center, Lone Tree
Kaiser Permanente Oncology Clinic, Denver
Memorial Hospital, Colorado Springs
Arizona Oncology Associates, P.C., Tempe
Glendale Adventist Medical Center, Los Angeles
Beverly Hills Cancer Center, Beverly Hills
The Oncology Institute of Hope and Innovation, Whittier
Redlands Community Hospital, Redlands
St. Joseph Heritage Medical Group, Fullerton
Redwood Regional Oncology Center, Santa Rosa
Pacific Diabetes & Endocrine Center, Honolulu
Oncology Associates of Oregon, Eugene
MultiCare Regional Cancer Center - Auburn, Tacoma
Veterans Affairs Connecticut Healthcare System, West Haven
University of Iowa, Iowa City
Morristown Medical Center, Morristown
The Valley Hospital - Luckow Pavilion, Westwood
University of Toledo Medical Center, Toledo
Texas Oncology-Sherman, Sherman
Texas Oncology-Deke Slayton Cancer Center, Webster
Collaborators (1)
ARMO BioSciences
INDUSTRY
Eli Lilly and Company
INDUSTRY